Skip to main content
2025 DC/CSEM Professional Conference Main banner
On-Demand

Rare Disease Rounds

RDRS2 - Thyroid Eye Disease: An Endo-Ophtho-Patient collaboration

Friday, November 28, 2025
13:00 - 14:15 Toronto
Location: Room 205

    Speaker(s)

  • Isabelle Hardy, MD, FRCSC, DABO (she/her/hers)

    Associate Professor
    Université de Montréal
    University of Montreal
    Montreal, Quebec, Canada

    Disclosure(s): Amgen Canada: Advisory Board (Ongoing), Consultant (Ongoing); Genentech-Roche: Advisory Board (Ongoing), Consultant (Ongoing)

  • Afshan Zahedi, MD

    Medical Director, Thyroid Program
    University of Toronto
    University of Toronto
    Toronto, Ontario, Canada

    Disclosure information not submitted.

    • Moderator(s)

  • Alice YY Cheng, MD, FRCPC (she/her/hers)

    Endocrinologist and Associate Professor
    Trillium Health Partners & Unity Health Toronto
    University of Toronto
    Mississauga, Ontario, Canada

    Disclosure(s): Abbott Diabetes Care: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen Canada: Speaker/Honoraria (Ongoing); Aspen: Consultant (Ongoing); Astellas: Speaker/Honoraria (Ongoing); Astra zeneca: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bausch Health: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer Canada Inc: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Biomea: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Speaker/Honoraria (Ongoing); Eisai Pharmaceuticals: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Gan & Lee: Advisory Board (Ongoing); GlaxoSmithKline (GSK): Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic Diabetes Canada: Speaker/Honoraria (Ongoing); MSD: Advisory Board (Ongoing); Novo Nordisk Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer Canada: Speaker/Honoraria (Ongoing); Sandoz: Consultant (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Consultant (Ongoing)

Disclosure(s):
Isabelle Hardy, MD, FRCSC, DABO: Amgen Canada: Advisory Board (Ongoing), Consultant (Ongoing); Genentech-Roche: Advisory Board (Ongoing), Consultant (Ongoing)
Alice YY Cheng, MD, FRCPC: Abbott Diabetes Care: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Amgen Canada: Speaker/Honoraria (Ongoing); Aspen: Consultant (Ongoing); Astellas: Speaker/Honoraria (Ongoing); Astra zeneca: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bausch Health: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer Canada Inc: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Biomea: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Speaker/Honoraria (Ongoing); Eisai Pharmaceuticals: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Gan & Lee: Advisory Board (Ongoing); GlaxoSmithKline (GSK): Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Medtronic Diabetes Canada: Speaker/Honoraria (Ongoing); MSD: Advisory Board (Ongoing); Novo Nordisk Canada: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Pfizer Canada: Speaker/Honoraria (Ongoing); Sandoz: Consultant (Ongoing); Sanofi: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Vertex: Consultant (Ongoing)

Learning Objectives:

  • Define and stage thyroid eye disease;
  • Initiate endocrinologist-appropriate treatments;
  • Determine when to refer to ophthalmology;
  • Recognize the lived experience of thyroid eye disease.